Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 3690
Species: Rattus norvegicus
RGD Object: Gene
Symbol: Slc16a1
Name: solute carrier family 16 member 1
Acc ID: CHEBI:27899
Term: cisplatin
Definition: A diamminedichloroplatinum compound in which the two ammine ligands and two chloro ligands are oriented in a cis planar configuration around the central platinum ion. An anticancer drug that interacts with, and forms cross-links between, DNA and proteins, it is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary. Commonly but incorrectly described as an alkylating agent due to its mechanism of action (but it lacks alkyl groups).
Chemical ID: MESH:D002945
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Slc16a1multiple interactionsISOSLC16A1 (Homo sapiens)6480464CTD[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of SLC16A1 mRNA; Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC16A1 mRNA]PMID:21858171 PMID:30871063
Go Back to source page   Continue to Ontology report